BeiGene Welcomes Experienced Life Sciences Executive Olivier Brandicourt to Board of Directors

Crown Bioscience’s Global Oncology Research Facilities Achieve Prestigious ISO and CAP Accreditations

Multiple New Analyses Reinforce the Role of BAVENCIO® (avelumab) First-Line Maintenance as a Standard of Care in Patients with Locally Advanced or Metastatic Urothelial Carcinoma

Galderma Announces Regulatory Approval for Restylane® SHAYPE™, a New Hyaluronic Acid Injectable Designed for Augmenting the Chin Region

New Blue Shift Report From Arthur D. Little Assesses the Future of Synthetic Biology

Fujirebio and Agappe Enter into an Agreement on Business Collaboration in the Field of CLIA Based Immunoassay

Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer

Hyperice Expands IP Enforcement Action, Files Percussion Patent Infringement Lawsuits Against Sharper Image, HoMedics, Ekrin Athletics, and Over a Dozen Others

ELIQUENT Life Sciences Announces Acquisition of European-Focused Regulatory Partner: RApport Global Strategic Services

Takeda Named Global Top Employer for Seventh Consecutive Year

Timeline, a Swiss Longevity Biotech, Secures Pivotal Financing Round with Support from Strategic Global Industry Leaders, including L’Oréal and Nestlé

PDC*line Pharma and Partners Receive €8.1M From Walloon Region and Wallonia Health Cluster BioWin for Personalized Therapeutic Vaccine Project

TOXINS 2024: Galderma’s Phase III RelabotulinumtoxinA Results Demonstrate Positive Efficacy and Long Duration of Effect When Treating Frown Lines and Crow’s Feet Simultaneously

Xenco Medical Unveils the TrabeculeX Continuum, a Breakthrough Convergence of Digital Health and Biomaterials, at CES 2024 in Las Vegas, the World’s Largest Technology Conference

KBI Biopharma, Inc. and Argonaut Manufacturing Services, Inc. Forge Strategic Alliance to Support Global Biopharmaceutical Companies with Integrated Drug Substance and Drug Product Solutions

Women's Health Remains in Crisis Worldwide Even as COVID-19 Pandemic Wanes

Parse Biosciences Acquires Biomage

U.S. FDA Approves Takeda’s HYQVIA® as Maintenance Therapy in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Neuraptive Therapeutics Inc. Receives Orphan Drug Designation for its Lead Development Asset

ELIQUENT Life Sciences Announces Steve Purtell as Chief Financial Officer

QPS Significantly Enhances Mass Spectrometry Laboratory Capacity

Medidata Secures Top Honors in Everest Group’s Decentralized Clinical Trial Platforms PEAK Matrix® Assessment

Kolmar BNH’s HemoHIM gets dual recognition for fatigue improvement, immune enhancement

World’s First Kidney Tumor Treated Using the HistoSonics’ Edison® Histotripsy System

Neuraptive Therapeutics, Inc. Announces Achievement of Proof of Concept in The NEUROFUSE Study of NTX-001 for the Adjunct Treatment of Transected Peripheral Nerves

Biocytogen Enters into Bispecific Antibody Drug Conjugate Agreement with Radiance Biopharma

ENYO Pharma Announces a €39 Million Series C Financing and FDA Clearance to Advance Vonafexor in a Phase 2 Clinical Trial for Patients With Alport Syndrome

Validant Group of Companies Unite as ELIQUENT Life Sciences

World’s First Patients Treated With Novel Edison® Histotripsy System

Kenvue to Announce Fourth Quarter and Full Year 2023 Results on February 8, 2024

ReNAgade to Present at the Upcoming 42nd Annual J.P. Morgan Healthcare Conference

Merck Expands Colorectal Cancer Portfolio Through Licensing Agreement with Inspirna

Fujirebio Expands Its Alzheimer’s Disease Test Menu With the Much Awaited and Fully Automated Lumipulse® G pTau 217 Plasma Assay for Research Use Only (RUO)

CCM Biosciences Announces Launch of 5Prime Sciences Business Unit

Takeda Announces China NMPA Approval of LIVTENCITY® (maribavir) for the Treatment of Adults With Post-transplant Cytomegalovirus (CMV) Refractory to Prior Therapies

Biocytogen Enters into Multi-Target Antibody Agreement With Neurocrine Biosciences

Organon & Lilly Enter Commercialization Agreement in Europe for Two Migraine Medicines

DENTALIS Animal Health Awarded with VOHC Seal

Biocytogen Enters into Antibody Agreement with Ona Therapeutics to Develop Antibody-Drug Conjugates Targeting Solid Tumors

Lydia AI Expands Reach in Korea Through Strategic Partnerships with Hecto Data and Tobecon

Takeda Receives Positive CHMP Opinion for HYQVIA® as Maintenance Therapy in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

QPS Continues UPLC-HRMS Expansion Into Europe to Support Gene Therapy and Protein Drug Development

Parse Biosciences Closes $50 Million of Financing to Fuel Continued Worldwide Growth

Fujirebio and Sysmex Sign Agreement for the Supply of Reagent Raw Materials in the Field of Immunoassay

WHOOP Announces Its “Year In Review” Celebrating That 2023 Was the Year Human Performance Became a Lifestyle

AOP Health Receives Market Authorization for Landiolol in Canada

Forge Biologics Announces Publication in Human Gene Therapy on a Novel Finding That Changes a Fundamental Understanding of AAV Production

New Study Finds Significant Correlation Between Masimo ORi™ and Arterial Partial Pressure of Oxygen During One-Lung Ventilation

BIO KOREA 2024: Registration Now Open for Programs and Booths

Ferring and PharmaBiome Enter Into a New Microbiome R&D Collaboration and Exclusive Licensing Agreement